Optimus Pharma launched a new Anti-Parkinson’s Drug in India

Hyderabad (Telangana) [India], April 26: Optimus Pharma has announced today that it has received DCGI approval for its Anti-Parkinson’s drug Safinamide. Safinamide is indicated as adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease (PD) experiencing “off” episodes.

The burdens of Parkinson’s Disease (PD) are undeniably serious and increasing while various unmet needs remain, especially the absence of disease-modifying therapies, especially in Indian Market. Optimus believes Safinamide will give an additional option to healthcare professionals in the treatment of Parkinson’s and improve the quality of life of millions who are affected by Parkinson’s disease. A homegrown generic version of Safinamide developed by Optimus will assist in delivering robust treatment for Parkinson’s diseases in India with very high affordability and accessibility.

About Parkinson’s Disease

Parkinson’s disease (PD) is one of the most common neurologic disorders, affecting approximately 1% of individuals older than 60 years and causing progressive disability that can be slowed but not halted, by treatment. Parkinson’s disease is a movement disorder that causes involuntary movements and rigidity, as well as abnormal walking and posture. It is caused by an imbalance between two chemicals that transmit signals from the brain, dopamine, and acetylcholine.

Disclaimer:

Statements in this “Document” describing the Company’s objectives, projections, estimates, expectations, plans or predictions, or industry conditions or events may be “forward-looking statements” within the meaning of applicable securities laws and regulations. Actual results, performance, or achievements could differ materially from those expressed or implied. The Company undertakes no obligation to update or revise forward-looking statements to reflect developments or circumstances that arise or to reflect the occurrence of unanticipated developments/circumstances after the date hereof.

Health

Sankara Eye Foundation, India Unveils First-of-its Kind Innovation Lab for Eye Care in the Country

The R&D Innovation Lab is dedicated to creating need-based solutions that go beyond existing options, ensuring world-class eye care access for all including the most remote villages in the country Coimbatore (Tamil Nadu) [India], June 18:  Sankara Eye Foundation, India has launched the country’s first-of-its-kind Innovation Lab supported by G.D. Naidu Charities, focused on advancing […]

Read More
Business

Herbs and Hills: Where Nature Meets Nurture

New Delhi (India), June 17: Forget chemicals, embrace the earth! Herbs & Hills, a groundbreaking skin and body care company, aims to be your go-to source for natural, sustainable self-care. Imagine indulging in luxurious products that are kind to your skin and kind to the planet. That’s the Herbs & Hills promise! Our philosophy is simple: […]

Read More
Business

CEAT Specialty Collaborates with Kalki 2898 AD for the Launch of Futuristic Tyres for AI Vehicle

New Delhi (India), June 17:  CEAT Specialty has announced an exciting partnership with the much-anticipated film Kalki 2898 AD, starring Prabhas, to develop and launch state-of-the-art tyres for Bujji, the robotic vehicle featured in the movie. This collaboration highlights CEAT’s cutting-edge technology and reinforces its commitment to driving the future of mobility.  Kalki 2898 AD, […]

Read More